Remove .Net Remove 2016 Remove Sales Remove Startup
article thumbnail

The Five Major Tech Trends of 2016

Xconomy

As we draw closer to the end of 2016, it is important that we take a moment to look back and reflect on all of the ways technology has inspired us, and transformed the way we live and do work. To augment and overcome physical distance, we are starting to use drones, virtual reality, and driverless cars. The Continued Growth of Cloud.

article thumbnail

United Dwelling is one startup building something to solve California’s housing crisis

TechCrunch LA

After wrestling with recalcitrant homeowners, husbanding their parcels of land to keep their property values high, the state’s leadership passed a law that increased the availability of new rental units and put more money into homeowners’ pockets in 2016. “We go to the homeowner and say you have this property here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. The idea was to feature early stage companies in the region that have not attracted much attention or raised a substantial amount of startup capital.

article thumbnail

Is Venture Capital A Path To Riches?

InfoChachkie

Thus, it’s entirely appropriate that founders net substantially more than the VC partners associated with their company. A few of the 2016 presidential candidates have indicated their intent to change the rate at which venture returns are taxed. Follow John’s startup-oriented Twitter feed here: @johngreathouse. Share and Enjoy.

article thumbnail

How To Embrace Disruptive Technologies And Succeed

Startup Professionals Musings

All too often as a startup investor, I hear the term “disruptive technology” from an entrepreneur, played like a trump card that should override any other potential business qualms. While struggling to net out what they are looking for, I found help in a new book, “ Wicked Strategies ,” by John C.

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. —The FDA last summer approved two new cholesterol fighting drugs known as PCSK9 inhibitors, but so far the market has rejected them, resulting in paltry sales. Talk about sacrifice.

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. —Pfizer wasn’t done after scooping up Medivation.

Pricing 40